Affiliation:
1. Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA
Abstract
Alzheimer’s disease (AD), which was first identified more than a century ago, has become a pandemic that exacts enormous social burden and economic tolls as no measure of combating devastated AD is currently available. Growing etiopathological, genetic, and biochemical data indicate that AD is a heterogeneous, polygenic, multifactorial, and complex disease. However, its exact etiopathology remains to be determined. Numerous experimental data show that cerebral iron and copper dyshomeostasis contribute to Aβ amyloidosis and tauopathy, two neuropathological hallmarks of AD. Moreover, increasing experimental evidence suggests ferroptosis, an iron-dependent and nonapoptotic form of cell death, may be involved in the neurodegenerative process in the AD brain. Thus, the anti-ferroptosis approach may be an efficacious therapeutic strategy for AD patients. Furthermore, it remains to be further determined whether cuproptosis, a copper-dependent and distinct form of regulated cell death, also plays a contributing role in AD neurodegeneration. We hope this concise review of recent experimental studies of oxidative stress-mediated ferroptosis and cuproptosis in AD may spur further investigations on this timely and essential line of research.
Reference65 articles.
1. Über einen eigenartigen schweren ErkrankungsprozeB der Hirnrinde;Alzheimer;Neurol. Cent.,1906
2. Über eine eigenartige Erkrankung der Hirnrinde;Alzheimer;Allg. Z. Fur Psychiatr. Und Psych. Gerichtl. Medizin.,1907
3. Redox-active metals, oxidative stress, and Alzheimer’s disease pathology;Huang;Ann. N. Y. Acad. Sci.,2004
4. WHO (2023, May 04). Dementia. Available online: https://www.who.int/news-room/fact-sheets/detail/dementia.
5. (2023). 2023 Alzheimer’s disease facts and figures. Alzheimers Dement, 19, 1598–1695.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献